To determine whether the downregulation of Akt affected downstream targets and its specificity for tumor cell lines, we analyzed the expression levels of the most representative proteins involved in Akt signaling in breast cancer and normal breast epithelial cells. This evidence concerns the gene AKT1 and neoplasm.